Transparency Market Research (TMR) observes in a research report that the competitive landscape in the global apheresis market is likely to be intense owing to the fact that a few leading vendors hold a substantial share in the market. The future threat arising from new entrants is likely to be comparatively low over the coming years because of the license required for manufacturing equipment, technical expertise needed to venture into this field, and expensive nature of the manufacturing process, which is keeping the new players at bay. The focus on mergers, collaborations, and strategic collaborations is likely to be high in the coming years with leading companies looking forward to tighten their grip in the intensely competitive market and amid the growing cost related pressures. The leading companies in the market comprise B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi AG, Haemonetics Corporation, Terumo Corporation, and Asahi Kasei Medical Co. Ltd.
According to a TMR analyst, “The global market for apheresis is anticipated to exhibit a 10.2% CAGR between 2017 and 2025. In 2016, the market was worth US$1.85 bn and is likely to touch a valuation of US$4.33 bn by the end of 2025.” Based on procedure, the market has been segmented into erythrocytapheresis, leukapheresis, plateletpheresis, LDL apheresis, photopheresis, and plasmapheresis. Among all these, the market was reigned by the plasmapheresis segment in 2016 owing to the growing number of procedures pertaining to donor plasmapheresis across the globe. The segment is further estimated to experience an 8.9% CAGR over the course of the forecast period. Region-wise, the market is anticipated to be dominated by North America until the end of the forecast period. This growth can be attributed to the extensive development of the healthcare infrastructure in the region.
Expanding Scope of Apheresis Procedure Application to be Key Growth Facet
The huge ascent in the prevalence of chronic maladies worldwide has prompted an extensive demand for blood components for use medical products such as immunoglobulin, coagulation factors, plasma, and albumin. Additionally, strict safety regulations are prompting the expanded concentration of healthcare facilities on the security and viability parts of these items, which has prompted specialized advances in apheresis items and techniques. In this manner, the rising interest for blood parts and plasma for therapeutics is anticipated to remain a key constrain affecting the general advancement of the worldwide apheresis market in the following couple of years.
The market is additionally anticipated to profit by the enlarging set of therapeutic apheresis, which is provoking the expanded utilization of apheresis methodology in the treatment of various ailments and signs. According to the American Society for Apheresis' (ASFA) Apheresis rule's 2016 version, there are 87 ailments (78 out of 2013 release) and 179 sign for apheresis. In 2016, three new hematological signs were included these rules. Such enlarging utilizations of apheresis is anticipated to drive development for apheresis market in the coming years.
High Initial Cost Might Push End users Towards Alternatives
The set-up of apheresis includes expensive disposables and apheresis systems. Furthermore, technically skilled operators are needed to conduct these procedures. This further, raises the cost of the operations, thus, making the complete procedure expensive. This type of situation also becomes a Herculean state in developing economies. Apheresis is also termed unaffordable for treating certain other diseases in which several other alternatives are also available which are equally efficient in treating the disease and are inexpensive as well. This issue is anticipated to have a huge impact on the growth of the global market for apheresis.
This review of the market is based on a recent report by Transparency Market Research, titled “Apheresis Market (Product - Devices and Disposables; Application - Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases, and Cardiovascular Diseases; Procedure - Plasmapheresis, Photopheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, and Erythrocytapheresis; Technology - Centrifugation and Membrane Filtration; End User - Private Blood Collection Centers, Public Blood Collection Centers, and Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025.”
For the study, the market has been segmented as follows:
Global Apheresis Market, by Product
Global Apheresis Market, by Application
- Renal diseases
- Autoimmune disease
- Cardiovascular diseases
- Others (e.g. Fibrosis, Diabetes, etc.)
Global Apheresis Market, by Procedure
- Others (e.g. lymphapheresis, extracorporeal immunoadsorption, etc.)
Global Apheresis Market, by Technology
- Membrane Filtration
Global Apheresis Market, by End User
- Blood Collection Centers
Global Apheresis Market, by Geography
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453